(Q33814323)

English

Most patients with cancer-associated dermatomyositis have antibodies to nuclear matrix protein NXP-2 or transcription intermediary factor 1γ.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Most patients with cancer-associated dermatomyositis have antibodies to nuclear matrix protein NXP-2 or transcription intermediary factor 1γ. (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

dermatomyositis

0 references

1 reference

based on heuristic

inferred from title

author name string

David F Fiorentino

1

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Lorinda S Chung

2

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Lisa Christopher-Stine

3

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Lisa Zaba

4

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Shufeng Li

5

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Andrew L Mammen

6

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Antony Rosen

7

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Livia Casciola-Rosen

8

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

publication date

1 November 2013

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Arthritis & Rheumatology

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

65

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

2954-2962

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Anti-melanoma differentiation-associated protein 5-associated dermatomyositis: expanding the clinical spectrum.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073292

4 July 2018

Myositis autoantibodies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073292

4 July 2018

Anti-MJ/NXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositis/dermatomyositis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073292

4 July 2018

Usefulness of anti-p155 autoantibody for diagnosing cancer-associated dermatomyositis: a systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073292

4 July 2018

The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): a retrospective study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073292

4 July 2018

Novel autoantibodies and clinical phenotypes in adult and juvenile myositis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073292

4 July 2018

Myositis autoantibodies in Korean patients with inflammatory myositis: anti-140-kDa polypeptide antibody is primarily associated with rapidly progressive interstitial lung disease independent of clinically amyopathic dermatomyositis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073292

4 July 2018

Incidence of dermatomyositis and clinically amyopathic dermatomyositis: a population-based study in Olmsted County, Minnesota

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073292

4 July 2018

RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: Association with rapidly progressive interstitial lung disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073292

4 July 2018

Defining cancer risk in dermatomyositis. Part I.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073292

4 July 2018

Autoantibodies to a 140-kd protein in juvenile dermatomyositis are associated with calcinosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073292

4 July 2018

The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073292

4 July 2018

A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis siné myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073292

4 July 2018

Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073292

4 July 2018

Dermatomyositis: an overview of recent progress with emphasis on dermatologic aspects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073292

4 July 2018

Polymyositis and dermatomyositis (first of two parts)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073292

4 July 2018

The RIG-I-like receptor IFIH1/MDA5 is a dermatomyositis-specific autoantigen identified by the anti-CADM-140 antibody

1 reference

https://api.crossref.org/works/10.1002%2FART.38093

21 January 2018

Anti-MDA5 antibody is associated with A/SIP and decreased T cells in peripheral blood and predicts poor prognosis of ILD in Chinese patients with dermatomyositis.

1 reference

https://api.crossref.org/works/10.1002%2FART.38093

21 January 2018

Clinical correlations with dermatomyositis-specific autoantibodies in adult Japanese patients with dermatomyositis: a multicenter cross-sectional study.

1 reference

https://api.crossref.org/works/10.1002%2FART.38093

21 January 2018

Anti-NXP2 autoantibodies in adult patients with idiopathic inflammatory myopathies: possible association with malignancy.

1 reference

https://api.crossref.org/works/10.1002%2FART.38093

21 January 2018

Development of an ELISA for detection of autoantibodies to nuclear matrix protein 2.

1 reference

https://api.crossref.org/works/10.1002%2FART.38093

21 January 2018

A novel autoantibody to a 155-kd protein is associated with dermatomyositis

1 reference

https://api.crossref.org/works/10.1002%2FART.38093

21 January 2018

Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24037894

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical associations of autoantibodies to a p155/140 kDa doublet protein in juvenile dermatomyositis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24037894

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical and serologic characterization of an Argentine pediatric myositis cohort: identification of a novel autoantibody (anti-MJ) to a 142-kDa protein

1 reference

https://pubmed.ncbi.nlm.nih.gov/24037894

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-MDA5 and anti-TIF1-gamma antibodies have clinical significance for patients with dermatomyositis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24037894

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analysis of dermatomyositis-specific autoantibodies and clinical characteristics in Japanese patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/24037894

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Myositis-specific anti-155/140 autoantibodies target transcription intermediary factor 1 family proteins

1 reference

https://pubmed.ncbi.nlm.nih.gov/24037894

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1002/ART.38093

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33814323&oldid=1634279857"